Merck KGaA (OTCMKTS:MKGAF – Get Free Report) reached a new 52-week high during trading on Thursday . The company traded as high as $170.3750 and last traded at $170.3750, with a volume of 16 shares trading hands. The stock had previously closed at $155.71.
Merck KGaA Stock Up 4.7%
The stock has a 50-day moving average price of $146.15 and a 200-day moving average price of $143.61. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a market capitalization of $22.02 billion, a P/E ratio of 26.01 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
- Getty Images’ OpenAI Deal Gives the Stock a New AI Licensing Story
- Cerebras Systems, Inc: The Next Rags-to-Riches AI Story?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
